Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Oct 9;177(43):V03150248.

[Low Dose Naltrexone for Treatment of Pain]

[Article in Danish]
Affiliations
  • PMID: 26509454
Review

[Low Dose Naltrexone for Treatment of Pain]

[Article in Danish]
Karin Bruun Plesner et al. Ugeskr Laeger. .

Abstract

Recent years have seen an increasing interest in the use of low dose naltrexone (LDN) for off-label treatment of pain in diseases as fibromyalgia, multiple sclerosis and morbus Crohn. The evidence is poor, with only few randomized double-blind placebo-controlled studies. The studies currently available are reviewed in this paper. LDN could be a potentially useful drug in the future for the treatment of pain in fibromyalgia, but more studies are needed to verify that it is superior to placebo, and currently it cannot be recommended as first-line therapy.

Similar articles

See all similar articles

MeSH terms

LinkOut - more resources

Feedback